TITLE

Troglitazone for insulin-resistant diabetes

PUB. DATE
April 1997
SOURCE
American Family Physician;4/1/1997, Vol. 55 Issue 5, p1985
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information about the approval of the Food and Drug Administration on troglitazone (Rezulin) as the first anti-diabetes drug that targets the underlying cause of type II diabetes mellitus. Required dosage of troglitazone for patients receiving insulin injection; Most common adverse effects of the anti-diabetes drug; Contraindication of troglitazone drugs.
ACCESSION #
9705162843

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics